GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharma. Regulatory News (CEL)

Share Price Information for Celadon Pharma. (CEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 83.00
High: 83.00
Low: 82.50
Prev. Close: 83.00
CEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation of Listing

9 Sep 2009 16:26

RNS Number : 7983Y
Celsis International PLC
09 September 2009
 



CELSIS INTERNATIONAL PLC

("Celsis", "the Company" or "the Group")

Notice of application of cancellation of Listing

9 September 2009Celsis International plc, the life sciences products and laboratory services company, today announces that following the announcement earlier today that Nastor Investments Limited ("Nastor Investments") either owned or had received valid acceptances in respect of, in aggregate, 16,513,640 Celsis Shares, carrying approximately 75.4 per cent. of voting rights attached to the existing issued share capital of Celsis and that as a result, Nastor Investments would now procure the making of an application by Celsis for the cancellation of the listing of Celsis Shares on the Official List and the admission to trading of Celsis Shares on the London Stock Exchange, Celsis has made an application for the cancellation of the listing of Celsis Shares on the Official List and the admission to trading of Celsis Shares on the London Stock Exchange. 

It is anticipated that cancellation of the Celsis listing and admission to trading will take effect on 8 October 2009, being the required notice period, such notice period having now commenced, of not less than 20 business days following the date of this announcement.

General

Terms used in this announcement shall have the meaning given to them in the Offer Document dated 10 August 2009, unless the context requires otherwise. 

In accordance with Rule 19.11 of the City Code, a copy of this announcement will be published on the following websites: www.navalue.co.uk/site/literature/NASTOR/ and www.celsis.com/about-our-company/news-room/financial-news/2009/. 

 

Copies of the Offer Document and Form of Acceptance will be available from the offices of Capita Registrars, Corporate Actions, The Registry, 34 Beckenham RoadBeckenhamKent BR3 4TU. The Offer Document may also be obtained from the website of Celsis, www. celsis.com/about-our-company/news-room/financial-news/2009/.

PRESS ENQUIRIES

For further information contact: 

Enquiries:

Celsis International plc

Tel: 01223 598 428

Jay LeCoque

Robyn LaLonde

Nomura Code Securities

Tel: 020 7776 1200

Chris Collins

Phil Walker

Financial Dynamics

Tel: 020 7831 3113

Jonathan Birt

Susan Quigley

This announcement does not constitute, or form part of, any offer for, or any solicitation of any offer for, securities. Any response to the Offer should be made only on the basis of information referred to in the Offer Document which Nastor Investments sent to Celsis Shareholders and, for information only, to holders of options under the Celsis Share Schemes on 10 August 2009.

The availability of the Offer to persons who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdiction in which they are located. Such persons should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdiction. Any failure to comply with these requirements may constitute a violation of the securities laws at any such jurisdiction. Further details in relation to overseas shareholders are contained in the Offer Document.

The Offer referred to in this announcement is not being made available directly or indirectly, in, into or by use of the mails of, or by any means or instrumentality (including, without limitation, telephonically or electronically) or interstate or foreign commerce of, or any facilities of a nationals securities exchange of, the United States, Canada, Australia or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction. This announcement does not constitute an offer in the United States, Canada, Australia or Japan or any such other jurisdiction and the Offer is being made available by any such use, means, instrumentality or facilities or otherwise from or within the United States, Canada, Australia or Japan or any such other jurisdiction. Accordingly this announcement is not being, and should not be, mailed, transmitted or otherwise distributed, in whole or in part, in or into or from the United States, Canada, Australia or Japan or any such other jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSSFIUSUSEEU
Date   Source Headline
7th Jun 20247:00 amRNSSecond Admission of Shares
3rd Jun 20245:45 pmRNSPublication of Annual Report & Notice of AGM
23rd May 20247:00 amRNSSupply of Products to New US Customer
15th May 20242:45 pmRNSExercise of Share Options and Total Voting Rights
14th May 20247:00 amRNSFinal Results
10th May 20247:00 amRNSFundraise, RCF Extension, Termination of CLN & TVR
7th Mar 20247:00 amRNSEarly Economic Analysis of Feasibility Study Data
14th Dec 20237:00 amRNSProduct Supplied to First Two Sales Contracts
12th Dec 20232:00 pmRNSFundraise, Update on Future CLN Financing & TVR
16th Nov 20237:00 amRNSNew European Sales Contract
13th Oct 20237:00 amRNSFundraise, CLN Issue, Joint Broker Appointed & TVR
28th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSNotice of Results and Investor Presentation
5th Sep 20237:00 amRNSNew Sales Contract with UK Pharmaceutical Company
1st Aug 20237:00 amRNSApproval to roll-out chronic pain clinical trial
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.